William Blair Analysts Decrease Earnings Estimates for SLP

Simulations Plus, Inc. (NASDAQ:SLP) – Analysts at William Blair cut their Q2 2026 EPS estimates for shares of Simulations Plus in a research report issued on Friday, April 4th. William Blair analyst M. Smock now expects that the technology company will post earnings of $0.30 per share for the quarter, down from their prior forecast of $0.31. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Simulations Plus’ current full-year earnings is $1.09 per share. William Blair also issued estimates for Simulations Plus’ Q3 2026 earnings at $0.34 EPS and FY2026 earnings at $1.25 EPS.

A number of other equities analysts have also weighed in on the stock. StockNews.com upgraded shares of Simulations Plus from a “sell” rating to a “hold” rating in a research report on Friday. KeyCorp boosted their price target on shares of Simulations Plus from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Simulations Plus currently has an average rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Trading Down 3.3 %

Shares of SLP stock opened at $24.83 on Monday. Simulations Plus has a twelve month low of $23.01 and a twelve month high of $51.22. The business’s 50 day moving average is $29.84 and its two-hundred day moving average is $30.22. The company has a market capitalization of $498.88 million, a P/E ratio of 62.08 and a beta of 1.13.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to the consensus estimate of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business’s quarterly revenue was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.20 earnings per share.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Simulations Plus by 4.4% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,103 shares of the technology company’s stock valued at $254,000 after acquiring an additional 380 shares during the last quarter. Jones Financial Companies Lllp grew its position in shares of Simulations Plus by 53.6% in the fourth quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after purchasing an additional 427 shares during the last quarter. Pitcairn Co. grew its position in shares of Simulations Plus by 10.8% in the fourth quarter. Pitcairn Co. now owns 7,310 shares of the technology company’s stock valued at $204,000 after purchasing an additional 711 shares during the last quarter. US Bancorp DE increased its stake in shares of Simulations Plus by 14.3% during the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after purchasing an additional 713 shares in the last quarter. Finally, Barclays PLC raised its position in shares of Simulations Plus by 2.7% during the 4th quarter. Barclays PLC now owns 29,229 shares of the technology company’s stock worth $815,000 after purchasing an additional 756 shares during the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Insider Activity at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $33.91, for a total transaction of $678,200.00. Following the completion of the transaction, the director now directly owns 3,402,584 shares of the company’s stock, valued at approximately $115,381,623.44. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 19.40% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.